Munshi, M. N., Venditti, E. M., Tjaden, A. H., Knowler, W. C., Boyko, E. J., Middelbeek, R. J. W., Luchsinger, J. A., Lee, C. G., Hazuda, H. P., Salive, M. E., Edelstein, S. L., & Storer, T. W. (2024). Long-term impact of Diabetes Prevention Program interventions on walking endurance. Frontiers in Public Health, 12. https://doi.org/10.3389/fpubh.2024.1470035

Seaquist, E. R., Phillips, L. S., Ghosh, A., Baker, C., Bergenstal, R. M., Crandall, J. P., Goland, R. S., Gramzinski, M. R., Hox, S. H., Hsia, D. S., Johnson, M. L., Lachin, J. M., Raskin, P., Valencia, W. M., Waltje, A. H., & Younes, N. (2024). Glycemia reduction in type 2 diabetes—Hypoglycemia outcomes: A randomized clinical trial. PLOS ONE, 19(11), e0309907. https://doi.org/10.1371/journal.pone.0309907

Tahmi, M., Benitez, R., & Luchsinger, J. A. (2024). Metformin as a Potential Prevention Strategy for Alzheimer’s Disease and Alzheimer’s Disease Related Dementias. Journal of Alzheimer’s Disease, 101(s1), S345–S356. https://doi.org/10.3233/jad-240495

Patel, M., Battarbee, A. N., Refuerzo, J. S., Zork, N., Eichelberger, K., Ramos, G. A., Olson, G., Durnwald, C., Landon, M. B., Aagaard, K. M., Wallace, K., Scifres, C., Rosen, T., Mulla, W., Valent, A., Longo, S., & Boggess, K. A. (2024). Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm Preeclampsia. Obstetrics & Gynecology, 144(5), 733–739. https://doi.org/10.1097/aog.0000000000005720

Bao, A., Qadri, A., Gadre, A., Will, E., Collins, D., Ahima, R., Bordone, L. A., & Aguh, C. (2024). Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia. JAMA Dermatology, 160(11), 1211. https://doi.org/10.1001/jamadermatol.2024.3062

Venkatesh, K. K., MacPherson, C., Clifton, R. G., Powe, C. E., Bartholomew, A., Gregory, D., Trinh, A., McAlearney, A. S., Fiechtner, L. G., Catalano, P., Rice, D., Cross, S., Kutay, H., Gabbe, S., Grobman, W. A., Costantine, M. M., Battarbee, A. N., Boggess, K., Katukuri, V., … Landon, M. B. (2024). Comparative effectiveness trial of metformin versus insulin for the treatment of gestational diabetes in the USA: clinical trial protocol for the multicentre DECIDE study. BMJ Open, 14(9), e091176. https://doi.org/10.1136/bmjopen-2024-091176

Shahidehpour, A., Rashid, M., Askari, M. R., Ahmadasas, M., Abdel-Latif, M., Fritschi, C., Quinn, L., Reutrakul, S., Bronas, U. G., & Cinar, A. (2024). Modeling Metformin and Dapagliflozin Pharmacokinetics in Chronic Kidney Disease. The AAPS Journal, 26(5). https://doi.org/10.1208/s12248-024-00962-2

Papachristodoulou, A., Heidegger, I., Virk, R. K., Di Bernardo, M., Kim, J. Y., Laplaca, C., Picech, F., Schäfer, G., De Castro, G. J., Hibshoosh, H., Loda, M., Klocker, H., Rubin, M. A., Zheng, T., Benson, M. C., McKiernan, J. M., Dutta, A., & Abate-Shen, C. (2024). Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression. European Urology, 85(4), 361–372. https://doi.org/10.1016/j.eururo.2023.07.016

Tzaridis, T., & Wechsler-Reya, R. J. (2024). Just a spoonful of metformin helps the medicine go down. Journal of Clinical Investigation, 134(6). https://doi.org/10.1172/jci179144

Barbera, M., Lehtisalo, J., Perera, D., Aspö, M., Cross, M., De Jager Loots, C. A., Falaschetti, E., Friel, N., Luchsinger, J. A., Gavelin, H. M., Peltonen, M., Price, G., Neely, A. S., Thunborg, C., Tuomilehto, J., Mangialasche, F., Middleton, L., Ngandu, T., … Solomon, A. (2024). A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol. Alzheimer’s Research & Therapy, 16(1). https://doi.org/10.1186/s13195-023-01355-x

Rasouli, N., Younes, N., Ghosh, A., Albu, J., Cohen, R. M., DeFronzo, R. A., Diaz, E., Sayyed Kassem, L., Luchsinger, J. A., McGill, J. B., Sivitz, W. I., Tamborlane, W. V., Utzschneider, K. M., Kahn, S. E., Crandall, J. P., McKee, M. D., Behringer-Massera, S., Brown-Friday, J., … Xhori, E. (2024). Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial. Diabetes Care, 47(4), 580–588. https://doi.org/10.2337/dc23-1070

Boggess, K. A., Valint, A., Refuerzo, J. S., Zork, N., Battarbee, A. N., Eichelberger, K., Ramos, G. A., Olson, G., Durnwald, C., Landon, M. B., Aagaard, K. M., Wallace, K., Scifres, C., Rosen, T., Mulla, W., Valent, A., Longo, S., Young, L., Marquis, M. A., … Berry, D. (2023). Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Early Pregnancy. JAMA, 330(22), 2182. https://doi.org/10.1001/jama.2023.22949

Goodwin, P. J., Chen, B. E., Gelmon, K. A., Whelan, T. J., Ennis, M., Lemieux, J., Ligibel, J. A., Hershman, D. L., Mayer, I. A., Hobday, T. J., Bliss, J. M., Rastogi, P., Rabaglio-Poretti, M., Thompson, A. M., Rea, D. W., Stos, P. M., Shepherd, L. E., Stambolic, V., & Parulekar, W. R. (2023). Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer. Journal of Clinical Oncology, 41(35), 5356–5362. https://doi.org/10.1200/jco.23.00296

Gadde, K. M., Yin, X., Goldberg, R. B., Orchard, T. J., Schlögl, M., Dabelea, D., Ibebuogu, U. N., Watson, K. E., Pi‐Sunyer, F. X., Crandall, J. P., Temprosa, M., & Luchsinger, J. A. (2023). Coronary Artery Calcium and Cognitive Decline in the Diabetes Prevention Program Outcomes Study. Journal of the American Heart Association, 12(21). https://doi.org/10.1161/jaha.123.029671

Tahmi, M., & Luchsinger, J. A. (2023). Metformin in the Prevention of Alzheimer’s Disease and Alzheimer’s Disease Related Dementias. The Journal of Prevention of Alzheimer’s Disease. https://doi.org/10.14283/jpad.2023.113

Nolan, N. D., Jenny, L. A., Tsang, S. H., & Cui, X. (2023). Rod Photoreceptor-Specific Ablation of Metformin Target, AMPK, in a Preclinical Model of Autosomal Recessive Retinitis Pigmentosa. Retinal Degenerative Diseases XIX, 403–408. https://doi.org/10.1007/978-3-031-27681-1_59

Hershman, D. L., Chen, B. E., Sathe, C., Parulekar, W. R., Lemieux, J., Ligibel, J. A., Gelmon, K. A., Whelan, T. J., & Goodwin, P. J. (2023). Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32). Breast Cancer Research and Treatment, 200(1), 93–102. https://doi.org/10.1007/s10549-023-06922-2

Domalpally, A., Whittier, S. A., Pan, Q., Dabelea, D. M., Darwin, C. H., Knowler, W. C., Lee, C. G., Luchsinger, J. A., White, N. H., Chew, E. Y., Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., Chatellier, A., Dragg, A., Champagne, C. M., Duncan, C., … Hivert, M.-F. (2023). Association of Metformin With the Development of Age-Related Macular Degeneration. JAMA Ophthalmology, 141(2), 140. https://doi.org/10.1001/jamaophthalmol.2022.5567

Zhu, W., Ding, C., Huang, P., Ran, J., Lian, P., Tang, Y., Dai, W., & Huang, X. (2022). Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-09610-1

Krigel, A., Nguyen, S. T. T., Talukder, N., Huang, C.-H., Buitrago, C., Karkenny, G., Lebwohl, B., Abrams, J. A., & Araujo, J. L. (2022). Metformin Use Is Inversely Associated with Prevalent, but Not Incident Colorectal Adenomas. Digestive Diseases and Sciences, 67(10), 4886–4894. https://doi.org/10.1007/s10620-021-07336-0

Wang, Z., Luo, J., Zhang, Y., Xun, P., & Chen, Z. (2022). Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis. PLOS ONE, 17(7), e0271038. https://doi.org/10.1371/journal.pone.0271038

Goodwin, P. J., Chen, B. E., Gelmon, K. A., Whelan, T. J., Ennis, M., Lemieux, J., Ligibel, J. A., Hershman, D. L., Mayer, I. A., Hobday, T. J., Bliss, J. M., Rastogi, P., Rabaglio-Poretti, M., Mukherjee, S. D., Mackey, J. R., Abramson, V. G., Oja, C., Wesolowski, R., Thompson, A. M., … Parulekar, W. R. (2022). Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer. JAMA, 327(20), 1963. https://doi.org/10.1001/jama.2022.6147

Acheampong, T., Lee Argov, E. J., Terry, M. B., Rodriguez, C. B., Agovino, M., Wei, Y., Athilat, S., & Tehranifar, P. (2022). Current regular aspirin use and mammographic breast density: a cross-sectional analysis considering concurrent statin and metformin use. Cancer Causes & Control, 33(3), 363–371. https://doi.org/10.1007/s10552-021-01530-1